| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 43,534 | 42,395 | 44,311 | | Cost of Revenue | 26,457 | 25,583 | 28,801 | | | Gross Profit | 17,077 | 16,812 | 15,510 | | | Operating Expenses | | Research Development | 3,884 | 3,502 | 2,451 | | Selling General and Administrative | 10,708 | 12,513 | 13,558 | | Non Recurring |
-
|
-
| 758 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 2,485 | 797 | (1,257) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (658) | (983) | 92 | | Earnings Before Interest And Taxes | 1,827 | (186) | (1,165) | | Interest Expense | 1,546 | 1,924 | 2,322 | | Income Before Tax | 281 | (2,110) | (3,487) | | Income Tax Expense | 584 | 338 | 325 | | Minority Interest | (41) | (96) | (13) | | | | Net Income From Continuing Ops | (344) | (2,544) | (3,825) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (344) | (2,544) | (3,825) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($344) | ($2,544) | ($3,825) |
|
0.01% Nasdaq 
0.22%
Income Statement
